Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

ABT

Abitare In (ABT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
DataOraFonteTitoloSimboloCompagnia
09/07/200507:21PR Newswire (US)Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)BIT:ABT
14/06/200523:00PR Newswire (US)Getting Arms Around Childhood Obesity Focus of Colorado SummitBIT:ABT
10/06/200518:54PR Newswire (US)Abbott Declares 326th Consecutive Quarterly DividendBIT:ABT
12/05/200517:55PR Newswire (US)Recent College Graduates Find Success at AbbottBIT:ABT
27/04/200517:00PR Newswire (US)Creative Way to Calm a Fussy Baby May Win a 'Fuss-Free' Trip For MomBIT:ABT
11/04/200520:00PR Newswire (US)Abbott Named No. 5 to DiversityInc's Top 50 Companies for Diversity listBIT:ABT
05/04/200514:00PR Newswire (US)Abbott Joins National Program to Help Millions of Uninsured Americans Get the Prescription Medicines They NeedBIT:ABT
11/02/200521:12PR Newswire (US)FDA Agrees to File Abbott's New Drug Application for Xinlay(TM) (Atrasentan) to Treat Metastatic Hormone-Refractory Prostate CanBIT:ABT
25/01/200516:00PR Newswire (US)FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients Suspected of Having Bladder CancerBIT:ABT
15/12/200417:55PR Newswire (US)TAP Submits New Drug Application for Febuxostat for the Management of Hyperuricemia in Chronic GoutBIT:ABT
01/11/200417:24PR Newswire (US)Longest Study of Kaletra(R) (Lopinavir/Ritonavir) Based Regimen Demonstrated Favorable Resistance Profile for Patients Through SBIT:ABT
01/11/200416:00PR Newswire (US)/C O R R E C T I O N -- Abbott Laboratories/BIT:ABT
28/10/200420:00PR Newswire (US)Superstar Patti LaBelle Encourages Americans to Manage Diabetes 365 Days a YearBIT:ABT
15/09/200417:00PR Newswire (US)Abbott's On-Site Child Care Center Recognized Amongst the Country's BestBIT:ABT
27/07/200417:00PR Newswire (US)Abbott Laboratories Introduces First Fully Automated Test for Hepatitis A VirusBIT:ABT
14/07/200423:14PR Newswire (US)U.S. District Court Dismisses Claims Against Abbott Laboratories' Anti-Obesity Medication Meridia(R) (Sibutramine HCL MonohydratBIT:ABT
14/07/200415:30PR Newswire (US)Kaletra(R) (lopinavir/ritonavir) Based Regimens Demonstrate Favorable Resistance in Clinical TrialsBIT:ABT
24/06/200405:08PR Newswire (US)U.S. Food and Drug Administration (FDA) Denies Abbott's Citizen Petition Regarding Levothyroxine Sodium ProductsBIT:ABT
22/06/200416:00PR Newswire (US)New Campaign Aims to Inspire People With Diabetes to Experience 'Diabetes Freedom'BIT:ABT
11/06/200402:24PR Newswire (US)Abbott Laboratories' Statement Regarding FDA'S DDMAC Letter on Norvir(R) (Ritonavir Capsules) MaterialsBIT:ABT
10/06/200415:00PR Newswire (US)ReAct Study Shows Abbott's Humira(R) (Adalimumab) Significantly Reduces Signs and Symptoms in Patients Battling Rheumatoid ArthrBIT:ABT
07/06/200416:01PR Newswire (US)Abbott and Protein Design Labs Announce Broad, Long-Term Collaboration for Humanized Therapeutic AntibodiesBIT:ABT
06/06/200400:30PR Newswire (US)Meta-Analysis Results Presented at ASCO Show Statistically Significant Delay in Time to Disease Progression for Advanced ProstatBIT:ABT
01/06/200416:30PR Newswire (US)Abbott Laboratories Introduces 10 Clinical Chemistry TestsBIT:ABT
27/05/200416:30PR Newswire (US)Abbott Laboratories' Zemplar(R) (Paricalcitol Injection) Receives FDA Approval for Pediatric UseBIT:ABT
26/05/200420:00PR Newswire (US)Data Demonstrate Impact of Weight Loss With Sibutramine on Cardiovascular Risk Factors for Obese PatientsBIT:ABT
14/05/200401:37PR Newswire (US)Abbott Laboratories to Present at Banc of America Securities Health Care ConferenceBIT:ABT
06/05/200413:00PR Newswire (US)Abbott Laboratories Receives Positive Opinion for HUMIRA(R) Rheumatoid Arthritis Label Extension From European Medicines EvaluatBIT:ABT
13/04/200419:20PR Newswire (US)Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in PatientsBIT:ABT
12/04/200415:06PR Newswire (US)Abbott Laboratories Declares Special Dividend Distribution of Hospira StockBIT:ABT
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network